Molecular profiling of DLBCL patients treated in the PETAL trial
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Using whole-exome sequencing and shallow whole genome sequencing for simultaneous screening of mutations, copy number alterations, and translocations, 5 biology-based risk profiles could be reproduced in an independent cohort of DLBCL patients, from the PETAL trial.EGA study EGAS00001005828
创建时间：
2021-12-20
